Quince Therapeutics Inc.

NASDAQ: QNCX · Real-Time Price · USD
1.70
0.02 (1.19%)
At close: Aug 15, 2025, 3:59 PM
1.62
-4.71%
After-hours: Aug 15, 2025, 07:43 PM EDT

Quince Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
6.21M 20.75M 44.58M 69.72M
Short-Term Investments
34.57M 54.31M 45.6M 37.08M
Long-Term Investments
78K 78K 3.58M 19.93M
Other Long-Term Assets
9.51M 8.47M -1.03M 194K
Receivables
882K 993K 1M 1.13M
Inventory
n/a n/a n/a n/a
Other Current Assets
84K 81K 276K 367K
Total Current Assets
44.04M 77.44M 93.75M 111.67M
Property-Plant & Equipment
813K 619K 684K 1.43M
Goodwill & Intangibles
60.05M 81.3M 5.9M n/a
Total Long-Term Assets
70.44M 90.46M 10.16M 21.55M
Total Assets
114.48M 167.9M 103.91M 133.23M
Account Payables
2.9M 2.03M 570K 4.91M
Deferred Revenue
n/a n/a n/a 8.39M
Short-Term Debt
96K 64K 453K 741K
Other Current Liabilities
212K 5.07M 463K -8.95M
Total Current Liabilities
7.28M 9.57M 3.07M 14.22M
Long-Term Debt
14.32M 13.43M n/a n/a
Other Long-Term Liabilities
57.38M 54.19M n/a n/a
Total Long-Term Liabilities
77.05M 73.24M 248K 420K
Total Liabilities
84.33M 82.82M 3.32M 14.64M
Total Debt
14.81M 13.81M 453K 1.16M
Common Stock
44K 43K 36K 30K
Retained Earnings
-376.47M -319.64M -288.26M -236.6M
Comprehensive Income
-35K 3.05M -289K -79K
Shareholders Equity
30.15M 85.08M 100.59M 118.59M
Total Investments
34.65M 54.38M 49.18M 57.01M